Importantly, the alpha2 chain of the IL-13 receptor (referred to as IL-13Rα2) is overexpressed in different solid tumors and correlates with poor prognosis in glioblastoma, colorectal cancer, adrenocortical carcinoma, pancreatic cancer, and breast cancer [53]. This evidence concerns the gene IL13RA2 and glioblastoma.